A new connector lets Function Health members bring lab results and biomarker trends straight into Meta’s personal AI agent, ...

Belgian clinical data show Allegro’s nanotech injection Hydrocelin delivers lasting knee osteoarthritis relief from a single ...

Alzheon’s peer-reviewed data tie a falling blood marker to slower memory and brain decline in patients taking its daily pill.

Seoul biotech’s redesigned method makes circular RNA up to seven times more efficient to build, widening what RNA medicine can treat.

NKGen presented new clinical data on troculeucel’s potential in Alzheimer’s, Parkinson’s and frontotemporal dementia.

With one in five citizens now 65 or older, Taiwan’s largest healthy-aging expo argued that older adults are a workforce to ...

Our new Longevity Biotech Report puts a number on longevity's payoff – and asks who actually gets to cash it in.

LOY-003, a daily tablet for large and giant breeds, has earned RXE acceptance, the third such milestone for a Loyal lifespan ...

Longevity brand launches a spray tech that skips gut entirely, betting that how a supplement is delivered matters as much as what’s in it.

Open benchmark tests whether AI can reason across aging biology – and finds specialist models can outperform far larger systems.

Inside the assumptions and interactive model behind our $617b longevity biotech TAM – and why you need not agree with us. With thanks to MuseCell Innovations, sponsor of the Longevity Biotech Report.

$71 million facility in Vilnius will manufacture patient-by-patient treatments, with ambitions stretching into longevity medicine. There was a ribbon, a crowd, the usual photo line-up of executives ...